TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $59.65M2014: $197.97M2015: $559.57M2016: $540.63M2017: $490.75M2018: $719.56M2019: $1.14B2020: $1.76B2021: $1.52B2022: $1.55B2023: $1.49B2024: $1.50B2025: $1.53B$1.53B
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$1.53B+1.9%
2024$1.50B+0.8%
2023$1.49B-3.5%
2022$1.55B+1.5%
2021$1.52B-13.5%
2020$1.76B+55.0%
2019$1.14B+57.8%
2018$719.56M+46.6%
2017$490.75M-9.2%
2016$540.63M-3.4%
2015$559.57M+182.7%
2014$197.97M+231.9%
2013$59.65M—